Literature DB >> 28004110

Effects of the regulation of polysialyltransferase ST8SiaII on the invasiveness and metastasis of small cell lung cancer cells.

Liang Gong1, Xiangdong Zhou1, Jingxiang Yang1, Yongyuan Jiang1, Heping Yang1.   

Abstract

Invasiveness and metastasis may seriously affect the prognosis of small cell lung cancer (SCLC). In the present study, we analyzed the effects and inherent mechanisms of action of polysialic acid-modified neural cell adhesion molecule (NCAM) on the invasive and metastatic potential of SCLC. Gene transfection and short hairpin RNA (shRNA) interference were used to enhance or inhibit, respectively, the expression of polysialyltransferase ST8SiaII in the SCLC cell line H446. We studied in vitro positive or negative changes in the invasive and metastatic potential of the SCLC cells as well as the changes in expression of genes related to signaling molecules and metastasis. When ST8SiaII expression was enhanced, the in vitro transmembrane invasion (P<0.01) and migration (P<0.01) abilities of the SCLC cells markedly increased. Phosphorylation levels of fibroblast growth factor receptor 1 (FGFR1), extracellular signal-related kinase 1/2 (ERK1/2), and matrix metalloproteinase-9 (MMP-9) in the SCLC cells were also significantly increased. In contrast, when ST8SiaII expression was inhibited, the transmembrane invasion (P<0.01) and migration (P<0.01) of the SCLC cells as well as expression of the above signaling molecules were suppressed. Polysialic acid-modified NCAM on the surface of SCLC cells is closely related to the metastatic potential of these cells; regulation of ST8SiaII may thus affect the invasiveness and metastasis of SCLC, and these processes may be associated with phosphorylation of FGFR1, ERK1/2 or MMP-9.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28004110     DOI: 10.3892/or.2016.5279

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  8 in total

Review 1.  Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic Opportunities.

Authors:  Emily Rodrigues; Matthew S Macauley
Journal:  Cancers (Basel)       Date:  2018-06-18       Impact factor: 6.639

2.  Characterization of Distinct Populations of Carcinoma-Associated Fibroblasts from Non-Small Cell Lung Carcinoma Reveals a Role for ST8SIA2 in Cancer Cell Invasion.

Authors:  Jing Hao; Cédric Zeltz; Melania Pintilie; Quan Li; Shingo Sakashita; Tao Wang; Michael Cabanero; Sebastiao N Martins-Filho; Dennis Y Wang; Elena Pasko; Kalpana Venkat; Joella Joseph; Vibha Raghavan; Chang-Qi Zhu; Yu-Hui Wang; Nadeem Moghal; Ming-Sound Tsao; Roya Navab
Journal:  Neoplasia       Date:  2019-04-09       Impact factor: 5.715

3.  Genome-Wide DNA Methylation Pattern of Cancer Stem Cells in Esophageal Cancer.

Authors:  Xiying Yu; Ying Teng; Xingran Jiang; Hui Yuan; Wei Jiang
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

Review 4.  The Distinct Roles of Sialyltransferases in Cancer Biology and Onco-Immunology.

Authors:  Marjolaine Hugonnet; Pushpita Singh; Quentin Haas; Stephan von Gunten
Journal:  Front Immunol       Date:  2021-12-17       Impact factor: 7.561

Review 5.  Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives.

Authors:  Nora Berois; Alvaro Pittini; Eduardo Osinaga
Journal:  Cancers (Basel)       Date:  2022-01-27       Impact factor: 6.639

Review 6.  Aberrant Sialylation in Cancer: Therapeutic Opportunities.

Authors:  Jennifer Munkley
Journal:  Cancers (Basel)       Date:  2022-08-31       Impact factor: 6.575

7.  Advances and challenges in immunotherapy of small cell lung cancer.

Authors:  Hanfei Guo; Lingyu Li; Jiuwei Cui
Journal:  Chin J Cancer Res       Date:  2020-02       Impact factor: 5.087

8.  Insight in Adhesion Protein Sialylation and Microgravity Dependent Cell Adhesion-An Omics Network Approach.

Authors:  Thomas J Bauer; Erich Gombocz; Markus Wehland; Johann Bauer; Manfred Infanger; Daniela Grimm
Journal:  Int J Mol Sci       Date:  2020-03-04       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.